The Alderley Park Discovery Podcast: Life science skills, staffing and supportEpisode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with Share XThe Alderley Park Discovery Podcast: Life science skills, staffing and supporthttps://pharmaphorum.com/podcast/alderley-park-life-science-skills-staffing/
5 ways digital health, and digital pharma, changed in 2020Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, Share X5 ways digital health, and digital pharma, changed in 2020https://pharmaphorum.com/digital/digital-health-pharma-in-2020/
Google’s Verily eyes 2021 growth after $700m funding roundVerily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors Share XGoogle’s Verily eyes 2021 growth after $700m funding roundhttps://pharmaphorum.com/news/google-verily-onduo-2021-growth-funding/
J&J and medical device innovation: the pharmaphorum podcastIn episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at Share XJ&J and medical device innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/johnson-medical-device-innovation/
Tay-Sachs and rare disease registries – the Health Heroes podcastEpisode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries Share XTay-Sachs and rare disease registries – the Health Heroes podcasthttps://pharmaphorum.com/podcast/rare-disease-registries-kantar-health/
Biotech trends in COVID era: the pharmaphorum podcastIn episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently Share XBiotech trends in COVID era: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/biotech-trends-pharnext-david-solomon/
OPEN Health Group promotes Rob Barker as CEORob Barker has been promoted to chief executive officer of Marlow, UK-based OPEN Health Group after serving as Share XOPEN Health Group promotes Rob Barker as CEOhttps://pharmaphorum.com/news/open-health-group-promotes-rob-barker-ceo/
We should allow ourselves to be #pharmaproudIn the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media Share XWe should allow ourselves to be #pharmaproudhttps://pharmaphorum.com/r-d/views-analysis-r-d/we-should-allow-ourselves-to-be-pharmaproud/
GSK and eosinophil research: the pharmaphorum podcastGlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Share XGSK and eosinophil research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-eosinophil-research/
